2nd World Congress on Clinical Trials in Diabetes, Berlin 2017 Berlin, Germany 27-28 November 2017

Description:
It is clear that there is a continuing necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.

Once again, our world renowned faculty will tackle issues head, on through a comprehensive program which will focus on key areas including:

Design the Best Study
Improve Regulatory Process
Better Understanding of How to Collaborate with Regulatory Authorities
Involvement of Digital Medicine
Management of Diabetes and Personalized Medicine

The scientific program will have a broad therapeutic focus and tackle both the global and specific regional differences. The program will include speakers such as physicians, RandD personnel, regulatory decision makers, CEOs, CROs, CRAs, Clinical Trial Managers and QA personnel.

URL:
Booking: https://go.evvnt.com/141697-1

Prices:
Industry starts from: USD 1300
Physician/Practicing Medical Professional/ Academic starts from: USD 650
Developing Countries starts from: USD 575

Speakers: Itamar Raz, Philip Home, Oilver Schnell, Ralph DeFronzo, Stefano del Prato, Roy Eldor, Markolf Hanefeld, Hiddo Lambers Heerspink, John Lachin, James Nolan, Andreas Pfützner, Paolo Pozzilli, Eberhard Standl, Giuseppe M.C. Rosano, Jane EB Reusch

Time: 8:00 am to 5:00 pm